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Developmental changes in gamma-aminobutyric acid levels in
attention-deﬁcit/hyperactivity disorder
S Bollmann1,2,3,4,5, C Ghisleni1,2,3, S-S Poil1,3, E Martin1,2, J Ball6, D Eich-Höchli7, RAE Edden8,9, P Klaver1,2,3,10, L Michels11,
D Brandeis2,3,6,12 and RL O'Gorman1,3,13
While the neurobiological basis and developmental course of attention-deﬁcit/hyperactivity disorder (ADHD) have not yet been
fully established, an imbalance between inhibitory/excitatory neurotransmitters is thought to have an important role in the
pathophysiology of ADHD. This study examined the changes in cerebral levels of GABA+, glutamate and glutamine in children and
adults with ADHD using edited magnetic resonance spectroscopy. We studied 89 participants (16 children with ADHD, 19 control
children, 16 adults with ADHD and 38 control adults) in a subcortical voxel (children and adults) and a frontal voxel (adults only).
ADHD adults showed increased GABA+ levels relative to controls (P= 0.048), while ADHD children showed no difference in GABA+
in the subcortical voxel (P40.1), resulting in a signiﬁcant age by disorder interaction (P= 0.026). Co-varying for age in an analysis of
covariance model resulted in a nonsigniﬁcant age by disorder interaction (P= 0.06). Glutamine levels were increased in children
with ADHD (P= 0.041), but there was no signiﬁcant difference in adults (P40.1). Glutamate showed no difference between controls
and ADHD patients but demonstrated a strong effect of age across both groups (Po0.001). In conclusion, patients with ADHD
show altered levels of GABA+ in a subcortical voxel which change with development. Further, we found increased glutamine levels
in children with ADHD, but this difference normalized in adults. These observed imbalances in neurotransmitter levels are
associated with ADHD symptomatology and lend new insight in the developmental trajectory and pathophysiology of ADHD.
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INTRODUCTION
Attention-deﬁcit/hyperactivity disorder (ADHD) is a common
developmental psychiatric disorder characterized by inattention,
hyperactivity and impulsivity with a prevalence of about 5%.1
Although traditionally considered a disorder of childhood,
mounting evidence suggests that ADHD often persists into
adulthood.2 While the neurobiological basis and developmental
course of ADHD have not yet been fully established, an imbalance
between inhibitory/excitatory neurotransmitters is thought to
have an important role in the pathophysiology of ADHD.3
GABA, the main inhibitory neurotransmitter in the human
cerebral cortex is synthesized from neuronal glutamate (Glu), and
converted back into Glu in astrocytes. The astrocytic Glu is then
catalyzed into glutamine (Gln) and transported to the presynaptic
neuron, where it is cycled back into Glu, some of which is then
converted into GABA.4 GABA has been shown to be implicated in
dopaminergic neurotransmission in the striatum5 suggesting an
important role in ADHD. Further, GABA seems to be important for
behavioral inhibition and self-control,6,7 as reduced GABA levels
are associated with high impulsivity, less cognitive control and
impaired response inhibition.
Glu, the major excitatory neurotransmitter, modulates the
release of dopamine,3 and imbalances in Glu are believed to
interfere with the gating of sensory information in striato-frontal
pathways in patients with ADHD.3
In children with ADHD, an increase in Glu+Gln (Glx) was
observed in frontal areas,8–10 right prefrontal cortex10,11 and left
striatum3,10,11 relative to controls, although these differences did
not reach signiﬁcance in a recent meta-analysis.12 Treatment with
stimulant medication has been reported to decrease Glx in the
basal ganglia in children with ADHD.13 However, there are also
studies reporting no signiﬁcant Glx differences with stimulant
treatment.14–16 In ADHD adults, on one hand increases in Glx have
been observed in the basal ganglia3 and in the left cerebellar
hemisphere.17 On the other hand, studies report a reduction in Glx
in the right anterior cingulate cortex,18 in a left midfrontal region19
and in the basal ganglia20 in adults with ADHD compared with
controls. As the magnetic resonance spectroscopy (MRS)-visible
Glx signal includes contributions from the metabolic Glx pool as
well as the neurotransmitter pool, the MRS Glx signal represents
only a nonspeciﬁc marker for neurotransmitter Glu. However,
since neurotransmitter Glu is converted into Gln in glial cells,21
some authors have suggested that Gln may represent a more
speciﬁc marker for neurotransmitter Glu.22–24
In children with ADHD, only one previous study has investi-
gated cerebral GABA+ concentrations, reporting reduced levels in
the sensorimotor cortex.25 However, to date, GABA+ has not been
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assessed in the basal ganglia in ADHD, although structural and
functional basal ganglia abnormalities appear to represent a core
ﬁnding in the ADHD literature, as highlighted in recent meta-
analyses.26,27 Further, no previous studies have investigated both
inhibitory and excitatory neurotransmission in both children and
adults with ADHD in a single study, and the developmental
trajectories of neurotransmitter levels in ADHD remain unclear,
despite the known developmental abnormalities observed in the
basal ganglia.28
The primary aim of this study was to investigate whether
inhibitory (GABA) and excitatory (Glu/Gln) neurotransmitter levels
in a subcortical voxel are altered in children and adults with ADHD.
A secondary aim was to investigate the relationship between
neurotransmitter levels and ADHD symptomatology and how
GABA, Gln and Glu change with development. For the ADHD
adults, we examined a left frontal region centered on the
dorsolateral prefrontal cortex in addition to the subcortical voxel.
We hypothesized that GABA+ levels would be reduced in ADHD
patients in the subcortical and frontal voxels, based on a recent
report of decreased GABA in the sensorimotor cortex in children
with ADHD.25 We also expected to ﬁnd increased levels of Glu in
children with ADHD.8–10
MATERIALS AND METHODS
The participant group consisted of 89 participants including 16 children
with ADHD and 19 control children, 16 adults with ADHD and 38 control
adults. Data were acquired as part of a large developmental study
investigating ADHD-related differences in GABA, Glu and Gln in the
context of the normal maturational changes in these neurotransmitter
systems. For this reason, a larger control group was recruited, but the
groups were matched for age, handedness and gender. One ADHD adult
was excluded because of recreational drug use. All participants complied
with magnetic resonance imaging (MRI) safety standards. The control
participants did not report any current or previous neurologic or
psychiatric diagnoses or any current use of psychoactive medications. All
spectra were inspected visually to assess ﬁt quality and the signal-to-noise
ratio, leading to the exclusion of one further adult ADHD patient and one
control child. One child was excluded from the control group due to
elevated ADHD symptom scores to avoid a confound due to subclinical
cases (Table 1 and Table 2). Because of the larger adult control group, all
analyses were additionally performed with a one by one matching of the
control subjects to the patients based on age and gender.
The ADHD adults were recruited from the Psychiatric University Clinic
Zürich and screened for comorbidities. All the patients were diagnosed
according to DSM-IV criteria, by a consultant psychiatrist specialising in
ADHD. To ensure a representative ADHD sample, we included participants
with current mild depressive symptoms, but excluded any patients with
major depression or current severe Axis I or II disorder, substance use
disorder, autism spectrum disorder, tic disorder or any other medical or
neurological illness affecting brain function. The ADHD children were
recruited by the Department of Child and Adolescent Psychiatry of the
University of Zurich. The Kiddie-Sads-Present and Lifetime clinical
interview29 was performed with all ADHD children to ensure the diagnosis
of combined ADHD and to exclude participants with comorbidities.
Participants taking stimulant medications were instructed to interrupt their
medication at least 72 h before the MRI measurements. Antidepressant
medication in six adult ADHD participants was not interrupted. A urine
toxicology test was not performed before scanning.
Symptom scores were assessed with the German version of the Conners’
Adult ADHD Rating Scale30 and the German short form of the Wender-Utah
Rating Scale.31 For children, we used the research version of the Conners-
3D32 and the strengths and difﬁculties questionnaires in their German
adaptations.33
After complete description of the study to the subjects, written informed
consent was obtained. For the ADHD and control children, written consent
was obtained from the parents and assent was obtained from the children.
The study was approved by the cantonal ethics committee of Zürich and
was conducted in accordance with guidelines of the Declaration of
Table 1. Demographic and clinical characteristics of the adult participants
n Mean (s.d.) Median Range P
Age
ADHD (m/f) 8/8 38.4 (11.8) 37.6 23.7–61.1 0.04a
Control (m/f) 19/19 31.6 (9.2) 27.5 21.0–50.6
WURS-k Sum
ADHD 16 33.4 (11.1) 34 13.0–51.0 o0.001a
Control 30 12.9 (10.4) 10 0.0–38.0
CAARS-S:L (ADHD-Index)
ADHD 16 63.0 (8.4) 62 51.0–79.0 o0.001a
Control 30 44.9 (5.7) 43 36.0–62.0
CAARS-O:L (ADHD-Index)
ADHD 13 64.6 (11.8) 63 49.0–83.0 o0.001b
Control 28 46.6 (6.1) 48 37.0–58.0
Medication
ADHD Methylphenidate (n= 14); trazodone (n= 2)c; dexmethylphenidate (n= 2); bupropion (n= 1); agomelatine (n= 1);
amitriptyline (n= 1)c; prednisone (n= 1); oral contraceptives (n= 3)
Control Finasteride (n= 1); ﬂuorouracil (n= 1)d; salicylic acid (n= 1); paracetamol (n= 1); minoxidil (n= 1); oral contraceptives
(n= 8)
Comorbidities
ADHD Sleep problems (n= 1)
Control None
Handedness
ADHD (r/l) 13/3
Control (r/l) 32/6
Abbreviations: ADHD, attention-deﬁcit/hyperactivity disorder; CAARS, Conners’ Adult ADHD Rating Scales; f, female; l, left-handed; m, male; n, number of
participants; r, right-handed; WURS, Wender Utah Rating Scale. aTwo-tailed Wilcoxon rank-sum test. bTwo-tailed two-sample t-test. cCurrent or previous
reported use for sleep problems. dPrescribed for skin warts.
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Helsinki. The participants received 60 Swiss Francs in vouchers for
participation in this study.
MR measurements were performed with a 3T GE HD.xt TwinSpeed MRI
scanner (GE Healthcare, Milwaukee, WI, USA), using an eight-channel
receive-only head coil. The MRI protocol included a T1-weighted spoiled
gradient echo scan (TR = 9.94 ms; TI = 600 ms; FOV=256 mm×192 mm;
matrix = 256× 192; ﬂip angle = 8°; axial plane; slice thickness = 1mm; 172
slices) for planning the positioning of the target voxels. GABA-edited MR
spectra were acquired using the MEGA-PRESS method with TE = 68ms,
TR= 2000ms, 320 averages (160 pairs) and an eight-step phase cycle. We
acquired spectra from a 28 × 40 × 25mm3 voxel in a subcortical region
centered on the left basal ganglia (also including anterior thalamus) from
all the participants. An additional 25 × 40× 30mm3 voxel was acquired in
the left frontal lobe, centered on the dorsolateral prefrontal cortex from
the adult participants (see Figure 1). The assessment of GABA with MEGA-
PRESS is confounded by the co-editing of macromolecules which
contribute to the edited peak at 3 p.p.m., so the GABA ﬁndings described
subsequently represent GABA+ rather than pure GABA values.
The T1-weighted images were segmented in native space using SPM8
with the ‘New Segment’ module (Wellcome Department of Cognitive
Neurology, London, UK) running in MATLAB 2012b (The MathWorks,
Natick, MA, USA) to correct the spectroscopy results for partial volume
cerebrospinal ﬂuid contamination and different water compartment
relaxation times.34
The spectra were coil combined with weighting factors derived from the
ﬁrst point of the free induction decay signal from the unsuppressed water
lines acquired with each coil. Water scaled metabolite concentrations were
derived with LCModel version 6.3-1B.35 The edited spectra were analyzed
with a simulated basis set including basis spectra for GABA, glutathione,
NAA, Gln, Glu and N-acetyl aspartyl glutamate. GABA+/H2O, Glu/H2O and
Gln/H2O were quantiﬁed from the edited spectra, using the control
parameter sptype= ‘mega-press-2’. The edited spectra provided a similar
ﬁt quality compared with the edit OFF MEGA-PRESS subspectra for Glu/
H2O, but a better ﬁt quality for Gln/H2O compared with the edit OFF
subspectra (Gln detected with Cramer–Rao lower bounds (CRLB) o30% in
73/89 edited spectra and 43/89 edit OFF subspectra). The CRLB for GABA
ranged from 2–10% for all participants. An estimate of general ﬁt quality
across each spectrum was assessed from the CRLB of the NAA ﬁt, both in
the edited spectra and in the edit OFF subspectra (edited spectra: NAA
CRLB= 1–3%, edit OFF subspectra: NAA CRLB= 1–5% for all cortical and
subcortical spectra).
Statistical analysis was performed using R 3.1.1 (ref. 36) and ggPlot2.37
Normality of the data was assessed using Quantile–Quantile plots of the
analysis of variance (ANOVA) residuals. ADHD-related and developmental
differences in subcortical GABA+ and Glu were assessed with a 2 × 2
ANOVA, including age group (adults and children) and diagnostic group
(ADHD and control) as ﬁxed factors. Post hoc t-tests were performed to
clarify the group differences. As the Gln levels were not normally
distributed, differences between ADHD and control participants were
tested using a two-tailed Wilcoxon rank-sum test. Correction for multiple
comparisons was performed with Benjamini and Hochberg correction, with
a false discovery rate (FDR) of 0.1.38 A multiple regression model was used
to investigate the relationship between metabolite levels and ADHD
symptom scores from the Conners’ inventory, age, methylphenidate dose
and gender, using the normally distributed data. To construct the ﬁnal
model, we started with the full model including gender, age, dose,
inattention/memory-score, hyperactivity-score, impulsivity-score and the
self-concept-score, then removed correlated regressors and ﬁnally
removed nonsigniﬁcant predictors in a stepwise manner until only
signiﬁcant predictors remained in the model.
RESULTS
GABA+/H2O—subcortical
The gray matter content of the subcortical voxel did not differ
signiﬁcantly between controls (M= 52%, s.d. = 3%) and ADHD
patients (M= 50%, s.d. = 5%; P40.1). However, there was a
signiﬁcant difference in gray matter content comparing adults
(M= 51%, s.d. = 4%) to children (M= 55%, s.d. = 4%; Po0.001).
Comparing GABA+/H2O levels in the subcortical voxel in
children and adults with and without ADHD revealed a signiﬁcant
age group by diagnostic group interaction (F(1,85) = 5.11,
P= 0.026, ω2 = 0.04; Figure 2), which remained signiﬁcant after
FDR correction for multiple comparisons. Post hoc t-tests demon-
strated that ADHD adults had higher GABA+/H2O values (M= 1.98,
s.d. = 0.20) compared with controls (M= 1.87, s.d. = 0.17). This
difference was signiﬁcant, t(52) = 2.03, P= 0.048, d= 0.56. ADHD
children showed no signiﬁcant differences in GABA+/H2O values
in the subcortical voxel (M= 1.85, s.d. = 0.17) compared with
controls (M= 1.91, s.d. = 0.13), t(33) =− 1.25, P40.1, d= 0.43.
The same analysis was repeated with the one by one matched
adult control group, resulting in similar results for the interaction
(F(1,63) = 5.56, P= 0.021, ω2 = 0.06), but the comparison between
GABA levels in ADHD adults and controls revealed only a trend
level difference (t(30) = 1.99, P= 0.055, d= 0.73), although the
effect size was comparable to that observed in the full control
group. Co-varying for age in an analysis of covariance model
resulted in a nonsigniﬁcant age group by diagnostic group
interaction in the full group (F(1,84) = 3.5, P= 0.06) but was
signiﬁcant in the one by one matched group (F(1,62) = 5.4,
P= 0.023).
The multiple regression in adults yielded standardized betas of
0.33 for age (P= 0.017) and 0.35 (P= 0.010) for self-concept with an
adjusted R2 of 0.26.
The regression analysis in children did not show any signiﬁcant
effects. There were no signiﬁcant differences in estimated ﬁt error
(Cramer–Rao lower bounds) between the groups.
Glu/H2O—subcortical
Comparing Glu/H2O differences in the subcortical voxel in children
and adults in a 2 × 2 ANOVA revealed a signiﬁcant main effect of
age group, F(1,85) = 40.6, Po0.001, ω2 = 0.31. The post hoc t-test
revealed that children have signiﬁcantly increased Glu/H2O values,
t(78) =− 6.59, Po0.001, d= 1.49 (see Figure 2) relative to adults.
The main effect of age on Glu/H2O levels remained signiﬁcant
after FDR correction for multiple comparisons. No signiﬁcant
Table 2. Demographic and clinical characteristics of the children
participants
n Mean (s.d.) Median Range P
Age
ADHD (m/f) 9/7 10.8 (1.1) 10.7 8.7–13.1 0.89a
Control (m/f) 11/8 10.8 (1.9) 11 8.1–14.7
Conners Parents ADHD-Index
ADHD 16 69.8 (3.1) 70 61.0–73.0 o0.001b
Control 19 46.9 (12.6) 46 20.0–63.0
SDQ Parents Total
ADHD 15 19.1 (6.5) 18 10.0–34.0 o0.001a
Control 19 5.1 (3.1) 5 1.0–14.0
Medication
ADHD Methylphenidate (n= 11)
Control None
Comorbidities
ADHD F40.2 speciﬁc (isolated) phobias (n= 4); F82
speciﬁc developmental disorder of motor function
(n= 2); F81.0 speciﬁc reading disorder (n= 1); F81.2
speciﬁc disorder of arithmetical skills (n= 1)
Control None
Handedness
ADHD (r/l) 12/4
Control (r/l) 18/1
Abbreviations: ADHD, attention-deﬁcit/hyperactivity disorder; f, female;
l, left-handed; m, male; n, total number of participants; r, right-handed;
SDQ, strengths and difﬁculties questionnaire. aTwo-tailed two-sample
t-test. bTwo-tailed Wilcoxon rank-sum test.
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difference between controls and ADHD in Glu/H2O values in the
subcortical voxel was observed, either for adults (t(52) = 0.07,
P40.1, d= 0.02) or for children (t(33) =− 0.45, P40.1, d= 0.16).
The Glu/H2O regression model in adults and children yielded no
signiﬁcant effect. There were no signiﬁcant differences in ﬁt errors
between ADHD and controls for Glu. However, Glu ﬁt errors were
signiﬁcantly higher in adults (Mdn= 5.4%) compared with children
(Mdn= 3.8%), W= 1477, Po0.001, r= 0.49.
The same analysis was repeated with the one by one matched
adult control group, resulting in similar results for the age group
effect (F(1,63) = 33.25, Po0.001, ω2 = 0.33). The comparison
between adults and children was still signiﬁcant t(64) =− 5.87,
Po0.001, d=− 1.47.
Gln/H2O—subcortical
The CRLB for Gln were o30% in 15/19 control children (range 13–
23%), 14/16 ADHD children (range 10–22%), 32/38 control adults
(range 10–29%) and 12/16 ADHD adults (range 11–28%). Using a
stricter cutoff of 20% would result in the exclusion of two
additional control children, two ADHD children, 15 control adults
and six ADHD adults.
ADHD adults (Mdn= 1.25) showed no signiﬁcant difference in
Gln/H2O compared with control adults (Mdn= 1.15), W= 229.0,
P40.1, r= 0.14. However, ADHD children (Mdn= 1.46) showed a
signiﬁcantly higher Gln/H2O level than control children (Mdn=
1.01), W= 152.0, P= 0.041, r= 0.38, which remained signiﬁcant
after FDR correction for multiple comparisons. There was no
signiﬁcant difference in Gln levels between adults (Mdn= 1.2) and
children (Mdn= 1.09), W= 726.0, P40.1, r= 0.11.
The Gln/H2O regression model was not performed due to non-
normality of the data. There were no signiﬁcant differences in ﬁt
errors between ADHD and controls for Gln. However, Gln ﬁt errors
were signiﬁcantly higher in adults (Mdn= 19.5%) compared with
children (Mdn= 16.00%) W= 918.0, P= 0.006, r= 0.32.
The same analysis was repeated with the one by one matched
adult control group, where ADHD adults (Mdn= 1.25) showed no
signiﬁcant difference in Gln/H2O compared with control adults
(Mdn= 1.22), W= 84.0, P40.1, r= 0.06. There was no signiﬁcant
difference in Gln levels between adults (Mdn= 1.25) and children
(Mdn= 1.09), W= 449.0, P40.1, r= 0.2.
GABA+/H2O—frontal
The gray matter content of the frontal voxel did not differ
signiﬁcantly between controls (M= 34%, s.d. = 3%) and ADHD
patients (M= 33%, s.d. = 4%; P40.1).
In the left frontal voxel, ADHD adults did not differ in GABA+/H2O
values (M=1.47, s.d. = 0.16) compared with controls (M=1.42,
s.d. = 0.17), t(51) =0.95, P40.1, d=0.26 (see Figure 2). This was also
the case for the one by one matched group (t(30) =0.02, P40.1;
d=0.01).
The multiple regression in adults yielded standardized betas of
0.58 for inattention/memory (P=0.003) and −0.37 (P=0.05) for
hyperactivity with an adjusted R2 of 0.15. There were no signiﬁcant
differences in GABA+ ﬁt errors between ADHD and controls (P40.1).
Glu/H2O—frontal
ADHD adults showed no difference in Glu/H2O values in the
frontal voxel (M= 3.7, s.d. = 0.4) compared with controls (M= 3.7,
s.d. = 0.4), t(51) = 0.12, P40.1, d= 0.03. This was also the case for
the one by one matched group (t(30) =− 1.07, P40.1; d= 0.39).
The multiple regression analysis in adults yielded no signiﬁcant
effects. There were no signiﬁcant differences in Glu ﬁt errors
between ADHD and controls (P40.1).
Gln/H2O—frontal
For this analysis, we excluded in total ﬁve Gln values with an
estimated ﬁt error (Cramer–Rao lower bound)430% (three ADHD
adults, two control adults) leaving in total 48 adults (13 patients) in
the analysis.
ADHD adults showed no difference in Gln/H2O values in the
frontal voxel (Mdn= 0.85) compared with controls (Mdn= 0.98),
W= 179.0, P40.1, r= 0.16. This was also the case for the one by
one matched group (W= 65, P40.1; d= 0.24).
The multiple regression analysis in adults was not performed
due to non-normality of the data. There were no signiﬁcant
differences in Gln ﬁt errors between ADHD and controls (P40.1).
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Figure 1. Left subcortical and left frontal voxel positions and representative spectra. The edited spectral ﬁts and the position of the left
subcortical and the left frontal voxel in a representative adult subject.
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DISCUSSION
The present study examined GABA+, Glu and Gln concentrations in a
subcortical voxel centered on the basal ganglia for the ﬁrst time in a
developmental group of children and adults with and without ADHD,
demonstrating a developmental alteration in GABA+ levels in ADHD
patients. GABA+ levels in the subcortical voxel were signiﬁcantly
correlated with ADHD symptom scores in adults. In addition, Gln
levels were signiﬁcantly increased in ADHD children but not in adults.
Figure 2. GABA+, Glu and Gln levels in the left subcortical and in the left frontal voxel GABA+/H2O (top row), Glu/H2O (middle row) and Gln/
H2O (bottom row) ratios from ADHD children, control children, ADHD adults and control adults in the subcortical voxel (left column) and in
the left frontal voxel (right column). ADHD, attention-deﬁcit/hyperactivity disorder; Gln, glutamine; Glu, glutamate.
Developmental course of ADHD
S Bollmann et al
5
Translational Psychiatry (2015), 1 – 8
The signiﬁcant interaction between age group and disorder
group in GABA+/H2O in the subcortical voxel was driven by
increased GABA+/H2O concentrations in ADHD adults compared
with control adults, in combination with mildly reduced GABA+/H2O
concentrations in ADHD children compared with control children.
Although the lower GABA+ levels in ADHD children are broadly
consistent with reports in the existing ADHD MRS literature,25 the
increased GABA+ concentration in ADHD adults was unexpected.
The GABA+ regression analysis revealed positive regression
coefﬁcients in adults for age and self-concept in the subcortical
voxel. In the frontal voxel, GABA+ was positively correlated with
inattention/memory but negatively correlated with hyperactivity
in adults.
Taken together with the observed group differences in GABA+
and the signiﬁcant age by disorder interaction, these results
provide evidence for a developmental alteration in subcortical
GABA+ levels in ADHD patients. The neurobiological basis for this
developmental change in GABA+ levels is unknown, but may
result from the progression of ADHD with brain maturation. The
developmental change in subcortical GABA+ levels is also broadly
consistent with results from structural MRI studies, which on one
hand report decreases in gray matter in the caudate and other
basal ganglia structures in children which show an apparent
normalization with development and treatment;26,28,39–41 whereas
on the other hand, subtle decreases in caudate gray matter in
adults with ADHD compared with controls can still be observed.42
In the present study, the subcortical voxel did not show any
signiﬁcant differences in gray matter content between the ADHD
and control groups, indicating that the apparent differences in
GABA+ observed in this region are independent of structural
differences which may arise from developmental or treatment
effects. Therefore, the observed developmental changes in GABA+
seem to relate to functional rather than structural differences.
Further, the regression results suggest that developmental
changes in GABA+ levels may at least partly underlie the apparent
change in ADHD symptomatology from childhood to adulthood.
It is possible that the signiﬁcant difference in GABA between
ADHD adults and controls might be driven by age differences.
When age was included as a covariate in the GABA+ ANOVA in
adults, the age by disorder interaction altered from F(1,85) = 5.11,
P= 0.026 to F(1,84) = 3.5, P= 0.06. In the one by one matched
group, the interaction was signiﬁcant in the ANOVA (F(1,63) = 5.56,
P= 0.021) and the analysis of covariance (F(1,62) = 5.43, P= 0.023).
However, the effect of age on GABA+ is not yet clear, as some
studies report a decline of GABA+ with age,43 while others
observed an increase of GABA+ with age.44 The reported increase
of GABA+ has also been reported to be driven by an increase of
the co-edited macromolecules with age and not GABA.44
We did not ﬁnd increased subcortical Glu levels in ADHD
patients compared with controls, as found in some previous
studies10,11,13,45 but not in others.12,25,46 However, most previous
studies investigated the ratio of Glx (the sum of Glu+Gln) to
creatine,3,11,15,16,47 rather than concentrations of Glx or Glu. Ratios
to creatine are simpler to derive since they do not require
correction for partial volume effects arising from cerebrospinal
ﬂuid in the MRS voxel, but the assessment of Glx/Cr ratios may be
confounded by alterations in striatal Cr levels, which have been
reported both in children10 and adults20 with ADHD. To our
knowledge, only two previous studies investigated Glx or Glu in
the left basal ganglia or striatum in ADHD, reporting an increase of
Glx and Glu in children aged 8 years,10 and a decrease in Glx in
both medication naive and medicated adults.20 These two
ﬁndings point towards a possible age interaction with Glu in the
striatum, such that Glu may be increased in children with ADHD
and decreased with age, resulting in lower Glu levels in adult
ADHD patients. However, in the present study, we did not observe
a signiﬁcant interaction between subcortical Glu levels and age or
a signiﬁcant effect in the regression analysis, although we did
observe a signiﬁcant main effect of age for Glu/H2O in the
subcortical voxel, with children showing higher Glu concentra-
tions than adults. Our regression analysis also suggests that Glu/
H2O decreases with age in children and adults, consistent with the
age decrease of Glx/Cr reported by Gao et al.,43 although their
results were derived from frontal and parietal regions.
To put our results into context with those from the literature, we
identiﬁed 10 previous studies investigating Glx or Glx/Cr in
the left basal ganglia/striatum in ADHD children or
adults.3,10,11,13,15,16,20,45,47,48 Two of these studies did not include
a healthy comparison group13,45 and one did not report group
means or effect sizes for Glx,48 but for the remaining seven
studies, we calculated the effect size (Cohen’s D) from the
difference between group means (ADHD–control) and the pooled
standard deviations for Glx/Cr or Glx. Where data were available
for multiple cohorts (for example, medicated vs unmedicated or
ADHD combined vs inattentive subtype), the effect sizes were
calculated separately for each ADHD cohort relative to the control
group. Effect size data are shown graphically in Supplementary
Figure 1. For the Glx/Cr ratios, studies showed either small positive
or negative effect sizes (both in children and adults), although
two studies showed a large increase in Glx/Cr in ADHD children
or young adults relative to a control group.3,11 For the Glx
concentration, data are only available for a small number of
studies, but children with ADHD tended to show positive effect
sizes (increased Glx) while adults with ADHD show smaller positive
or negative effect sizes (reduced Glx20), but further studies would
be needed to corroborate and extend this ﬁnding.
To our knowledge, the present study is the ﬁrst to examine Gln
changes in a developmental cohort of adults and children with
ADHD. We found increased Gln/H2O in the subcortical voxel in
children with ADHD, but there were no signiﬁcant differences in
Gln/H2O between ADHD and control adults. As Gln contributes to
the Glx signal, the increased Gln levels are consistent with results
from a previous study reporting increased Glx levels in children
with ADHD10,11 (Supplementary Figure 1). Assuming that Gln
represents a marker for neuronal Glu, the developmental
trajectory of Gln levels observed here points towards an increase
in excitatory neurotransmission in children with ADHD, which
normalizes with brain maturation. While the underlying basis of
this apparent increase in Gln remains unclear, the production and
subsequent pruning of excitatory synapses during late childhood
and adolescence could result in transiently increased Gln either
from a developmental lag or from a compensatory effect in
response to synaptic pruning. However, developmental changes
in neurotransmitter activity are likely to result from a complex
interplay between genetic and environmental factors including
activity-dependent increases in synaptic strength and neuroplastic
changes during adolescence. Further studies would be needed to
elucidate the basis for this apparent change in Gln.
In the frontal voxel, there was no signiﬁcant difference between
ADHD and control adults in GABA+/H2O, Glu/H2O or Gln/H2O.
Several methodological limitations are inherent in the detection
of GABA with MEGA-PRESS MRS. Due to the low cerebral
concentration of GABA, a large MRS voxel is required for sufﬁcient
sensitivity and signal-to-noise ratio, which limits the regional
speciﬁcity of the measurement. In addition, the assessment of
GABA with MEGA-PRESS is confounded by the co-editing of
macromolecules which contribute to the edited peak at 3 p.p.m.
Therefore, we cannot exclude the possibility that the differences in
GABA observed in the present study are confounded by
differences in the co-edited macromolecules between ADHD
patients and controls, but future studies using a MEGA-PRESS
protocol with reduced macromolecular contamination49 may be
able to clarify further the spectroscopic differences in GABA
in ADHD.
Although the developmental effects observed in subcortical
GABA+ levels and the signiﬁcant difference in Gln levels in
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children with ADHD relative to control children survived correc-
tion for multiple comparisons with a relatively lenient FDR
threshold of 0.1, these results did not survive correction with a
more stringent FDR threshold of 0.05. Given the sample size, the
relatively modest signiﬁcance levels are surprising, but may result
from the large variance seen both within and across age and
diagnostic groups (Figure 2). Alternatively, the modest effect size
may also be inﬂuenced by variability within diagnostic groups,
as evidenced by the relatively wide range of symptom scores
particularly in the adult ADHD group, which included some
patients with lower symptom scores indicative of a milder
phenotype. Although the groups were matched for gender, the
inclusion of female participants may also contribute to the large
group variance, as GABA+ and Glu have been shown to vary
signiﬁcantly with hormonal effects and throughout the menstrual
cycle.50 However, in our sample, the variance of males and females
did not differ for GABA+ in ADHD (F(1,7) = 4.7, P= 0.06) or control
adults (F(1,18) = 1.5, P= 0.39). The handedness was also carefully
balanced between groups but the inclusion of both left- and right-
handed participants may also contribute to the group variance.
Future multicenter or meta-analytic studies with larger group
sizes, or groups of male, right-handed participants only may be
able to elucidate further the developmental and ADHD effects
observed in the present study.
In addition, medication effects could introduce variance, even
though participants taking stimulants were asked to withdraw
from treatment for 72 h before the MRS session. While some
studies have reported a decrease in Glx levels following stimulant
treatment,45 others showed no change in Glx between medicated
and medication naive adults with ADHD.20 However, in addition to
psychostimulant medication for ADHD, four adult participants also
reported current or previous use of antidepressants within
1 month of the MRS measurement, for sleep problems. As
antidepressants have been shown to alter Glx51 and GABA
levels,52 to assess the potentially confounding effects of anti-
depressant treatment on the MRS results, the statistical compar-
isons were repeated after excluding all participants on
antidepressants. In this smaller subsample, the developmental
GABA+/H2O interaction was of borderline signiﬁcance with a
similar effect size (F(1,80) = 3.93, P= 0.05, ω2 = 0.03) compared with
F(1,85) = 5.11, P= 0.026, ω2 = 0.04 in the full group. The differences
in GABA+/H2O between ADHD and control adults were not
signiﬁcant anymore due to the smaller sample size, but showed a
similar effect size (t(47) = 1.58, P= 0.1, d= 0.46 compared with t
(52) = 2.03, P= 0.048, d= 0.56). Therefore, while the results do not
appear to be driven by medication effects, the variability in
medication status of the ADHD adults does represent a signiﬁcant
source of variance, and these results should be reproduced in a
sample of medication naive patients.
LCModel offers improved reproducibility for GABA detection
relative to alternative spectral analysis methods,53,54 but with the
default settings the baseline ﬁt can include a large fraction of the
GABA peak, introducing an error into the estimated GABA
concentrations. However, with the MEGA-PRESS-2 and MEGA-
PRESS-3 control parameters (available from version 6.3 onwards),
the default baseline ﬁtting in LCModel is turned off and this error
is reduced.
Although the CRLB cutoff used for Gln was relatively lenient
(30%), using a stricter cutoff of 20% resulted in the exclusion of
four additional children (two ADHD children and two control
children). In this smaller subset of participants, the group
difference in Gln in children was no longer signiﬁcant
(W= 112.0, P= 0.137, r= 0.30, compared with W= 152.0, P= 0.041,
r= 0.38 in the full group). However, as higher CRLB are expected
for lower concentration metabolites, using a strict CRLB cutoff for
low-concentration metabolites like Gln and GABA can introduce a
systematic bias toward higher concentrations as lower concentra-
tions are more likely to be excluded. This potential bias can
confound the analysis of group differences and should be
considered carefully when selecting a CRLB cutoff.
CONCLUSION
ADHD patients show altered levels of GABA+ in the subcortical
voxel (centered on the basal ganglia) which change with
development. Children with ADHD also show increased Gln levels
in the subcortical voxel, but this difference normalized in adults.
These imbalances in neurotransmitter levels are associated with
symptom scores and lend new insight in the development and
pathophysiology of ADHD.
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